InvestorsHub Logo
Followers 36
Posts 2833
Boards Moderated 0
Alias Born 10/02/2012

Re: Solantey post# 108558

Thursday, 09/18/2014 3:20:17 AM

Thursday, September 18, 2014 3:20:17 AM

Post# of 130513
Milestone, AMBS PAYS another company to get their product ready for market. They did not get money from that company. They will be sharing the profits with that company. The revenue from Lympro is noted by the company to be small in 2015. The long awaited PAY OFF for Lympro never showed up. LOL.

Milestone, Eltoprazine study will start in " early " 2015. LOL.

Milestone, the total number of shares will double to 2 Billion LOL.

Milestone, there WILL be a reverse split and uplisting to a major market, really it will be good for shareholder value. Really. LWOL.

There were other "postive" milestones. more laughing out loud.

Actual positive milestones. The MANF IP is getting wrapped up for sale. That can be very positive.

I do think the pps will continue to decline. These stocks almost always go back to their long term baseline at some point. The accurate level for that one is not clear. For sure, before the stock heads up again, it will base significantly. So that will be the sign.

Most importantly, when I was getting harangued for noting the delay in the Eltoprazine study, because I know how to interpret the things that they say, because I know the system, the company confirmed what I had been saying.

yea me. rofl yea me. more rolling on the floor laughing. yea me.

The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill